Pediatric Vaccines Market to Reach USD 62 Billion by 2027

The global pediatric vaccines market has witnessed remarkable growth, driven by the development of safe and efficacious vaccines against life-threatening infectious diseases. The market, valued at USD 47.8 billion in 2021, is expected to reach USD 62 billion by 2027, fueled by increasing demand for pediatric vaccines and the expansion of vaccination programs globally. Agencies such as the United Nations Children's Fund (UNICEF), World Health Organization (WHO), Gavi, The Bill & Melinda Gates Foundation, and the Vaccine Alliance have played a crucial role in expanding vaccine benefits to all, particularly in low- and middle-income countries.

Key Takeaways:

  • The global pediatric vaccines market is expected to reach USD 62 billion by 2027, growing at a CAGR of 7.3% from 2021 to 2027.
  • Pediatric vaccination has made a significant public health success story, saving the lives of billions of children and providing millions with the chance of a longer, healthier life.
  • The market share of Pediatric Vaccines for Coronavirus is expected to be significant, driven by the rapid development and implementation of COVID-19 vaccines.
  • The development, licensing, and implementation of Pediatric vaccines as part of large, systematic immunization programs have addressed global health inequities.
  • Agencies such as UNICEF, WHO, Gavi, and the Vaccine Alliance have been instrumental in expanding vaccine benefits to all, particularly in low- and middle-income countries.
  • The market is driven by the development of safe and efficacious vaccines against life-threatening infectious diseases, such as Influenza, MMR, Pneumococcal, Meningococcal, Hepatitis, DTaP, Hib, Combos, Polio, Rotavirus, and Varicella.
  • The number of vaccinated pediatric (infants) remains variable globally and is a significant concern.
  • Immunization efforts have reduced the scourge of diseases, enabling children to walk, play, dance, and learn.

Statistics:

  • Global Pediatric Vaccines Market size: USD 47.8 billion (2021)
  • Market growth rate: 7.3% CAGR from 2021 to 2027
  • Expected market size by 2027: USD 62 billion
  • Number of vaccinated pediatric (infants) varies by disease and region
  • Population and number of vaccinated pediatric (infants) for each disease (e.g., COVID-19, Influenza, MMR, etc.)

Sources:

  • ResearchAndMarkets.com
  • UNICEF (United Nations Children's Fund)
  • WHO (World Health Organization)
  • Gavi (Global Alliance for Vaccines and Immunization)
  • The Bill & Melinda Gates Foundation
  • Vaccine Alliance
  • Coalition for Epidemic Preparedness Initiative (CEPI)
  • GlaxoSmithKline, Plc
  • Merck & Co.
  • Sanofi Pasteur's
  • Pfizer, Inc.
  • CSL Limited